Today: October 23, 2016, 8:12 am

Global clinical trial supply market: New market research published
Clinical Trial Supply and Logistics: World Market Outlook 2013-2023 - a new market research report on 2014-03-26 07:49:03
What´s the outlook for the supplying and arrangement of medical testing? Our new report gives you revenue predictions, helping you stay ahead. There you see financial prospects. You also explore R&D trends, technologies, clients´ needs, and opportunities.

That study gives you revenue forecasts to 2023 at overall world market, submarket, and national level. See what´s happening, then, for those pharmaceutical contracting services - outsourcing and off-shoring - finding how you can gain.

Besides sales forecasting there to 2023, our new work shows historical data, growth rates, and market shares. There you find original analysis. See research and development (R&D) needs too. You also get 51 tables, 59 charts, and two interviews with companies.

Our study shows you what the future holds for pharma contract research organisations (CROs) and contract manufacturers (CMOs) supporting clinical trials.

You also see outlooks for related companies, including specialists in logistical support. See, too, implications for drug developers and clinical trial sponsors.

That knowledge could bring you quicker, easier decisions, and results. Also you gain understanding to benefit your authority on clinical testing of drugs.

Revenues for the world clinical trial supply and logistics market and its submarkets

What are the secrets of that industry´s progress? Along with prediction of the overall world market for that service provision, our work shows you individual revenue forecasting of three submarkets to 2023, at world level, for clinical trials:

• Manufacturing - also with forecasts for packaging and for other production
• Logistics and distribution - also with forecasts for cold chain logistics and for other services
• Supply chain management.

That report gives you feel for what stimulates and restrains that industry and market. There you identify potential for those technologies and services. See, then, how you can benefit.

Our analyses show you individual revenue forecasts to 2023 for 11 national markets:

• United States (US)
• Japan
• EU leaders - Germany, France, the UK, Italy, and Spain (EU5)
• BRIC countries - Brazil, Russia, India, and China.

For pharma service providers and clients, many opportunities exist in developed and developing countries. Progress worldwide will influence that market for outsourced services. See there how you and your organisation can benefit.

You find prospects. Our work explains, also exploring issues.

Developments, challenges, and opportunities affecting CROs, CMOs and other companies

The report explains forces affecting that industry and market from 2013, including these:

• Globalisation - access to new markets and patients
• Regulatory standards for clinical trial supply, inc. good manufacturing practice (GMP) and good distribution practice (GDP)
• Import regulations
• Supply chain security and other technology for developing and testing medicines
• Biological drugs (biologics) and other complex pharmaceuticals.

And also for these:

• Forecasting and modelling to maintain supply
• IT systems for clinical trial planning: IVRS and IWRS
• Participation in trials at home
• Adaptive clinical trials
• Management of multiple supplier networks.

What´s possible for that industry? Our report predicts the world market for that clinical trial support will reach $14.3bn in 2017, expanding to 2023.

That work also shows you what technologies and organisations hold greatest potential. In particular, you explore activities of these companies:

• Catalent Pharma Solutions
• Patheon
• Almac Group
• Parexel International
• Fisher Clinical Services (FCS).

Our study also covers these firms, among others:

• World Courier
• TNT Express
• FedEx
• Movianto.

You find 115 organisations covered. You also read interviews with two leaders in the industry. Discover, then, what participants do, say, and think, helping you stay ahead.

Through knowledge such as this, our new report helps you:

• Revenues to 2023 at world level for supporting clinical trials, with forecasts for 3 submarkets - assess prospects for investments, marketing, and revenues
• Forecasts to 2023 for 11 national markets in the Americas, Europe, and Asia -investigate developed and developing countries for potential sales
• Outlooks for established and rising service providers - assess results, portfolios, capabilities, clients, and prospects.

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Press Information

Published by
Mike King
London: +44 (0) 203 086 8600

# 837 Words
Related Articles
More From Finance
P2P lending platform Monexo partners with IDBI-Trusteeship [..]
For Immediate Release: 2nd September 2016 MUKESH BUBNA, CEO Monexo Fintech Pvt Limited P2P [..]
Day Trade to Win New September Class [..]
Sold Out? New Class Added – On September 6, 2016, is launching a brand new eight-week trading boot camp [..]
FTM (Forget The Market) Reopens 3 Shares [..]
Port Vila, Vanuatu, 28th July 2016 - Investment firm FTM today announced the reopening of three separate share options, projected [..]
Ex-Citibanker Launching Online P2P marketplace in India [..]
A study conducted by World Bank shows that MSMEs in India face an estimated credit gap of INR 20.9 trillion [..]
New Frontier Portfolios Top Morningstar Rankings
New Frontier’s global strategic portfolios topped the Global Balanced Strategic/All-Inclusive category of the latest Morningstar ETF [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.